Mouse Anti-6HIS IgG:Eu-W1024

Mouse Anti-6HIS IgG:Eu-W1024 （订货以CAS编码或英文名称为准）

Application|High-Throughput Screening||Application|Immunofluorescence||Application|TR-FRET||Product Type|Antibodies|Epitope Tag Antibodies|HIS||Product Type|Antibodies|Primary Antibodies|Monoclonal Antibodies||Research Area

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55274

分子式：C20H23NO4

CAS号：127017-69-0

分子量：341.40

储存条件：2-8

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55274-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC55274-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC55274-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC55274-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55274-1mg	Medlife	EA		¥63157.00	登录后可见
PC55274-50µg	Medlife	EA		¥14917.00	登录后可见
PC55274-20µg	Medlife	EA		¥7537.00	登录后可见

中文名称：	Paroxetine EP Impurity B
中文别名：	盐酸帕罗西汀半水盐酸杂质B;帕罗西汀杂质32(单体);盐酸帕罗西汀杂质50
英文名称：	Mouse Anti-6HIS IgG:Eu-W1024
英文别名：	Paroxetine EP Impurity B;(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine;Paroxetine HCl HeMihydrate IMpurity B HCl;4-Methoxy Paroxetine;(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine hydrochloride;Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)-, (3R,4S)-rel-;Paroxetine HCl Hemihydrate Impurity B (HCl salt);Paroxetine Hydrochloride Impurity 50
CAS号：	127017-69-0
分子式：	C20H23NO4
分子量：	341.40
详细描述	Application\|High-Throughput Screening\|\|Application\|Immunofluorescence\|\|Application\|TR-FRET\|\|Product Type\|Antibodies\|Epitope Tag Antibodies\|HIS\|\|Product Type\|Antibodies\|Primary Antibodies\|Monoclonal Antibodies\|\|Research Area

搜索质检报告(COA)

相关产品

((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol compound with ((3S,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol (1:1) hydrochloride

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro- [1,1'-biphenyl]-4-yl)piperidine-1-carboxylate

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate

(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound with (3S,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine(1:1) hydrochloride

(3S,3'S,4R,4'R)-diphenyl 3,3'-(oxybis(methylene))bis(4-(4- fluorophenyl)piperidine-1-carboxylate)

(3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-phenyl piperidine-1-carboxylate

((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate

(3S,3'S,4R,4'R)-3,3'-(oxybis(methylene))bis(4-(4-fluorophenyl)-1- methylpiperidine)

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'- biphenyl]-3-yl)piperidine hydrochloride

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'-biphenyl]-4-yl)-1-methylpiperidine hydrochloride